CUSIP: 57165B106
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,436,773
-
Share change
-
+20,683,939
-
Total reported value
-
$62,801,000
-
Price per share
-
$2.00
-
Number of holders
-
23
-
Value change
-
+$39,670,449
-
Number of buys
-
11
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 57165B106?
CUSIP 57165B106 identifies MBII - MARRONE BIO INNOVATIONS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 57165B106:
Institutional Holders of MARRONE BIO INNOVATIONS INC - COM (MBII) as of Q1 2018
As of 31 Mar 2018,
MARRONE BIO INNOVATIONS INC - COM (MBII) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,436,773 shares.
The largest 10 holders included
WADDELL & REED FINANCIAL INC, ARDSLEY ADVISORY PARTNERS, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Capital Planning Advisors, LLC, NORTHERN TRUST CORP, BARCLAYS PLC, and Laurel Wealth Advisors, Inc..
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.